Papers: 10.3390/cancers12010074
https://doi.org/10.3390/cancers12010074
A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Cited by: 19
Author(s): Fatih M. Uckun, Christopher R. Cogle, Tara L. Lin, Sanjive Qazi, Vuong Trieu, Gary J. Schiller, Justin M. Watts
Published: over 5 years ago
Software Mentions 4
Very Likely Science (100)
Very Likely Science (75)
Very Likely Science (75)
Very Likely Science (90)